Don’t let the high cost of brand or generic multiple sclerosis therapy disrupt your treatment. We help eligible patients access glatiramer acetate (Copaxone brand and generic injections) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
The Glatiramer Acetate Patient Assistance Program helps eligible patients access this MS therapy at little or no cost when meeting income, insurance, and clinical criteria. Multiple manufacturers offer PAPs — brand Copaxone and generic Glatopa (Sandoz).
At AffordMyPrescriptions, our Patient Advocates handle the entire enrollment for a flat $69.95 per month — so you never face a gap in your MS therapy.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your glatiramer acetate enrollment — so you never face a gap in your multiple sclerosis treatment.
| PHARMACY | PRICE (30-DAY) WITH BEST COUPONS | YOU SAVE W/ US |
|---|---|---|
| Older interferon (alt DMT) | ~$5,000/mo | Alt injectable DMT |
| Walgreens (brand) | ~$7,000/mo | Save substantially |
| CVS Pharmacy (brand) | ~$7,000/mo | Save substantially |
| Walmart (brand) | ~$6,000/mo | Save substantially |
| Generic Glatopa | ~$2,000/mo | Generic significantly cheaper |
| Sandoz generic | ~$2,500/mo | Generic significantly cheaper |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. AffordMyPrescriptions Advocacy Service bypasses pharmacy pricing entirely by using the manufacturer’s assistance program to secure your Glatiramer Acetate — independent of dosage or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
The Glatiramer Acetate Patient Assistance Program is free to apply. Our $69.95 per month covers full advocacy. Generic glatiramer acetate offers significant cost savings vs brand Copaxone. MS is a chronic disease requiring long-term therapy — accessible medication access is essential.
Complete a simple eligibility form so our team can determine if you may qualify for Glatiramer Acetate assistance.
Our specialists gather documentation, complete applications, and coordinate with your prescriber and the assistance program.
Once approved, your Glatiramer Acetate is delivered through the assistance program while we manage refills and annual renewals.
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Glatiramer Acetate:
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $2,000 generic / $6,000–$7,000 brand per month even with the best discount
Cannot be used with Medicare, Medicaid, or government insurance
Fixed $69.95/month — never changes regardless of retail price
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
If denied, we explore alternative savings paths on your behalf
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Glatiramer Acetate assistance.
Glatiramer acetate is a complex synthetic polypeptide mimicking myelin basic protein — modulating the T-cell response in multiple sclerosis. A long-standing, safe injectable MS disease-modifying therapy. Available as brand Copaxone and multiple generic products.
How It Works:
Multiple sclerosis is a chronic autoimmune disease of the central nervous system — immune-mediated demyelination and axonal loss cause neurological symptoms (motor, sensory, cognitive, visual). Disease-modifying therapies (DMTs) reduce relapses, slow disability accumulation, and reduce MRI lesion burden. Glatiramer acetate is a complex random polymer of glutamic acid, lysine, alanine, and tyrosine — designed to mimic the myelin basic protein antigen. It modulates the T-cell response, shifting from pro-inflammatory Th1 to regulatory Th2 responses, reducing MS relapse rates and MRI lesion accumulation. It has a long-standing safety record — one of the earliest MS DMTs. Available as brand Copaxone (Teva) and multiple FDA-approved generic products (Glatopa — Sandoz, and others).
Form and Use:
Glatiramer acetate SC injection. 20 mg SC daily, OR 40 mg SC 3 times weekly (48+ hours between doses). Self-administered at home after training. Injection site rotation is important. Generic and brand are equivalent per FDA.
Generic Availability:
Glatiramer acetate is available generic — significant cost savings. Generic Glatopa (Sandoz) and other generic manufacturers. Brand: Copaxone (Teva). Other MS disease-modifying therapies: interferons (Betaseron/Extavia, Rebif, Avonex, Plegridy — brand injections), oral MS therapy (Tecfidera generic dimethyl fumarate, Vumerity, Aubagio generic teriflunomide, Gilenya generic/brand fingolimod, Mayzent, Zeposia, Ponvory), monoclonal antibody infusions (Ocrevus IV every 6 mo, Kesimpta SC monthly, Tysabri IV every 4 wk, Lemtrada, Briumvi IV), oral cladribine (Mavenclad), off-label rituximab. National MS Society and MS specialty clinic resources. MS DMT selection is individualized.
Warnings:
Immediate post-injection reactions (chest pain, dyspnea, flushing, palpitations, anxiety — occur in ~15% of patients; usually within minutes of injection; self-limited; educate patients), injection site reactions (lipoatrophy, skin necrosis — rotate injection sites), hepatotoxicity (rare — monitor LFTs), and embryo-fetal considerations (generally safe in pregnancy compared to many DMTs). Other: injection site reactions, upper respiratory infections, headache, fatigue. Generally well-tolerated long-term — an older DMT with an extensive safety record.
Brand Copaxone: $6,000–$7,000 per month at retail pharmacies. Generic glatiramer acetate (Glatopa Sandoz and others): $2,000–$2,500 per month — significantly cheaper for equivalent therapy per FDA.
A long-standing injectable DMT with an extensive safety record. Modest efficacy compared to newer high-efficacy therapies (Ocrevus, Kesimpta, Tysabri) but excellent tolerability and safety including in pregnancy. Considered for patients preferring safety over maximum efficacy, in pregnancy planning, or as initial MS DMT in some contexts.
FDA has approved generic glatiramer acetate products (Glatopa — Sandoz, and others) as therapeutically equivalent to brand Copaxone. These complex polypeptide products underwent scientifically rigorous generic approval and are clinically bioequivalent — with significant cost savings.
Two dosing options: 20 mg SC daily OR 40 mg SC 3 times weekly (48+ hours between doses). Choose based on patient preference and prescriber recommendation. Both are effective. Self-administered at home after training.
~15% of patients experience transient reactions within minutes of injection: chest pain, dyspnea, flushing, palpitations, anxiety. Usually self-limited (minutes to hours). Not allergic — mechanism unclear. Rest and reassurance. Educate patients before starting. Not typically dangerous but can be concerning the first time.
MS disease-modifying therapy preserves neurological function long-term. Our advocacy team is ready — $69.95 per month, or free if we cannot help.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.